Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New psychopharmacological agents developed by Ferrer

Jan. 28, 1997

Spotlight on CCK-B antagonists for anxiety

Jan. 27, 1997

Medeva begins full development of ADHD Rx

Jan. 27, 1997

NK1 antagonists from Takeda

Jan. 27, 1997

Excitatory amino acid receptor ligands from Schering AG

Jan. 27, 1997

FDA approves Royce's generic narcotic pain reliever

Jan. 24, 1997

Royce Laboratories receives FDA approval for alprazolam

Jan. 24, 1997

SIBIA receives patent coverage for antiparkinson compounds

Jan. 24, 1997

Glaxo Wellcome selects anticonvulsant compound for further study

Jan. 24, 1997

New AMPA receptor modulator described by Servier

Jan. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...